1. Home
  2. PCM vs CPIX Comparison

PCM vs CPIX Comparison

Compare PCM & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PCM Fund Inc.

PCM

PCM Fund Inc.

HOLD

Current Price

$5.76

Market Cap

82.0M

Sector

Finance

ML Signal

HOLD

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$3.08

Market Cap

73.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCM
CPIX
Founded
1993
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.0M
73.6M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
PCM
CPIX
Price
$5.76
$3.08
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
44.8K
46.0K
Earning Date
01-01-0001
05-05-2026
Dividend Yield
11.68%
N/A
EPS Growth
N/A
58.70
EPS
N/A
N/A
Revenue
N/A
$42,010,949.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.75
52 Week Low
$5.52
$1.85
52 Week High
$6.76
$6.27

Technical Indicators

Market Signals
Indicator
PCM
CPIX
Relative Strength Index (RSI) 47.43 44.06
Support Level $5.52 $2.97
Resistance Level $5.83 $3.69
Average True Range (ATR) 0.09 0.19
MACD 0.03 0.03
Stochastic Oscillator 70.00 45.61

Price Performance

Historical Comparison
PCM
CPIX

About PCM PCM Fund Inc.

Pcm Fund Inc is a closed-end investment management company. Its investment objective is to seek current income as a primary focus and also capital appreciation. The Fund invests in agency-guaranteed mortgage-backed securities, private-label mortgage-backed securities, high-yield corporate debt securities, and commercial mortgage-backed securities.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: